Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (22352)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 28, 2015 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Zhang M. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol 2015; 21(48): 13432-13437 [PMID: 26730153 DOI: 10.3748/wjg.v21.i48.13432] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i48/13432.htm |
| Number | Citing Articles |
| 1 |
Matteo Masetti, Federico Falchi, Dario Gioia, Maurizio Recanatini, Stefano Ciurli, Francesco Musiani. Targeting the Protein Tunnels of the Urease Accessory Complex: A Theoretical Investigation. Molecules 2020; 25(12): 2911 doi: 10.3390/molecules25122911
|
| 2 |
Salma Burayzat, Mohammad Al-Tamimi, Mohammad Barqawi, Mustafa Sabri Massadi, Jumanah Abu-Raideh, Hadeel Albalawi, Ashraf I. Khasawneh, Nisreen Himsawi, Maha Barber. Antimicrobial Resistance Molecular Mechanisms of Helicobacter pylori in Jordanian Children: A Cross-Sectional Observational Study. Antibiotics 2023; 12(3): 618 doi: 10.3390/antibiotics12030618
|
| 3 |
Jianwei Ma, Takahiro Hiratsuka, Tsuyoshi Etoh, Junko Akada, Hajime Fujishima, Norio Shiraishi, Yoshio Yamaoka, Masafumi Inomata. Anti‐proliferation effect of blue light‐emitting diodes against antibiotic‐resistant Helicobacter pylori. Journal of Gastroenterology and Hepatology 2018; 33(8): 1492 doi: 10.1111/jgh.14066
|
| 4 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 5 |
Camelia Quek, Son T. Pham, Kieu T. Tran, Binh T. Pham, Loc V. Huynh, Ngan B.L. Luu, Thao K.T. Le, Kelly Quek, Van H. Pham. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Research 2016; 5: 671 doi: 10.12688/f1000research.8239.1
|
| 6 |
R. Contreras-Omaña, A.E. Escorcia-Saucedo, J.A. Velarde-Ruiz Velasco. Prevalencia e impacto de resistencias a antimicrobianos en infecciones gastrointestinales: una revisión. Revista de Gastroenterología de México 2021; 86(3): 265 doi: 10.1016/j.rgmx.2021.02.003
|
| 7 |
Güner KILIÇ, Gulce Ecem KİLİC, Adnan ÖZKAHRAMAN, Şevki KONÜR, Yusuf KAYAR. The effect of vitamin D levels on eradication rates of Helicobacter pylori infection. Hitit Medical Journal 2024; 6(1): 28 doi: 10.52827/hititmedj.1332272
|
| 8 |
Yuying Cai, Caixia Wang, Zhenghong Chen, Zhengzheng Xu, Huanjie Li, Wenjuan Li, Yundong Sun. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter 2020; 25(4) doi: 10.1111/hel.12715
|
| 9 |
Majid T. Moghadam, Zahra Chegini, Amin Norouzi, Amin S. Dousari, Aref Shariati. Three-Decade Failure to the Eradication of Refractory Helicobacter pylori Infection and Recent Efforts to Eradicate the Infection. Current Pharmaceutical Biotechnology 2021; 22(7): 945 doi: 10.2174/1389201021666200807110849
|
| 10 |
Aimen Qaiser, Maria Hassan Kiani, Rashida Parveen, Muhammad Sarfraz, Gul Shahnaz, Abbas Rahdar, Pablo Taboada. Design and synthesis of multifunctional polymeric micelles for targeted delivery in Helicobacter pylori infection. Journal of Molecular Liquids 2022; 363: 119802 doi: 10.1016/j.molliq.2022.119802
|
| 11 |
Yongfu Shao, Yifan Lin, Ziyi Fang, Jianing Yan, Tuo Zheng, Guoliang Ye. Analysis of Helicobacter pylori resistance in patients with different gastric diseases. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-55589-2
|
| 12 |
Yan Li, Yundong Sun, Wenchao Wang. Fractional order dynamics for clarithromycin against helicobacter pylori. 2017 6th Data Driven Control and Learning Systems (DDCLS) 2017; : 667 doi: 10.1109/DDCLS.2017.8068152
|
| 13 |
Maurício Palmeira Chaves de Souza, Bruna Almeida Furquim de Camargo, Larissa Spósito, Giovanna Capaldi Fortunato, Gabriela Corrêa Carvalho, Gabriel Davi Marena, Andréia Bagliotti Meneguin, Taís Maria Bauab, Marlus Chorilli. Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections. Critical Reviews in Microbiology 2021; 47(4): 435 doi: 10.1080/1040841X.2021.1895721
|
| 14 |
Gilberto Jaramillo-Trujillo, William Alberto Otero-Regino, Kelly Patricia Estrada-Orozco. Efectividad y seguridad del uso de probióticos como adyuvantes en la erradicación de Helicobacter pylori. Revisión sistemática y metaanálisis. Revista de la Facultad de Medicina 2022; 71(2): e98018 doi: 10.15446/revfacmed.v71n2.98018
|
| 15 |
Amitabha Ray, Thomas F. Moore, Rajashree Pandit, Adam D. Burke, Daniel M. Borsch. An Overview of Selected Bacterial Infections in Cancer, Their Virulence Factors, and Some Aspects of Infection Management. Biology 2023; 12(7): 963 doi: 10.3390/biology12070963
|
| 16 |
Francesco Musiani, Dario Gioia, Matteo Masetti, Federico Falchi, Andrea Cavalli, Maurizio Recanatini, Stefano Ciurli. Protein Tunnels: The Case of Urease Accessory Proteins. Journal of Chemical Theory and Computation 2017; 13(5): 2322 doi: 10.1021/acs.jctc.7b00042
|
| 17 |
Ivana Jukic, Doris Rusic, Jonatan Vukovic, Piero Marin Zivkovic, Josipa Bukic, Dario Leskur, Ana Seselja Perisin, Marko Luksic, Darko Modun. Correlation of registered drug packs with Maastricht V/Florence Consensus Report and national treatment guidelines for management of Helicobacter pylori infection. Basic & Clinical Pharmacology & Toxicology 2020; 126(3): 212 doi: 10.1111/bcpt.13322
|
| 18 |
Manal M. Sabry, Ahlam M. El-Fishawy, Ahmed A. El-Rashedy, Rania A. El Gedaily. Phytochemical Investigation of Cordia africana Lam. Stem Bark: Molecular Simulation Approach. Molecules 2022; 27(13): 4039 doi: 10.3390/molecules27134039
|
| 19 |
Nooshin Naghibzadeh, Fatemeh Salmani, Samira Nomiri, Tahmine Tavakoli. Investigating the effect of quadruple therapy with Saccharomyces boulardii or Lactobacillus reuteri strain (DSMZ 17648) supplements on eradication of Helicobacter pylori and treatments adverse effects: a double-blind placebo-controlled randomized clinical trial. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02187-z
|
| 20 |
Giuseppe Zanotti, Laura Cendron. Helicobacter pylori in Human Diseases. Advances in Experimental Medicine and Biology 2019; 1149: 227 doi: 10.1007/5584_2019_368
|
| 21 |
Jing Zhang, Jing Ning, Weiwei Fu, Yanyan Shi, Jing Zhang, Shigang Ding. CMTM3 protects the gastric epithelial cells from apoptosis and promotes IL-8 by stabilizing NEMO during Helicobacter pylori infection. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00533-4
|
| 22 |
Harpreet Singh, Hansol Chung, Imad Awan, Anjali Mone, Robert Cooper, Sanket Patel, Zoya Grigoryan, Yojiro Ishida, Charalampos Papachristou, Thomas Judge, Joshua DeSipio, Sangita Phadtare. Designing strategies for eradication of Helicobacter pylori based on prevalence patterns of infection and antibiotic resistance in a low‐income, medically underserved community in the United States. Helicobacter 2021; 26(1) doi: 10.1111/hel.12769
|
| 23 |
Sung Eun Kim, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Kwang Il Seo, Seong Kyeong Lim, Jin Kyu Jung, Hyeon Jin Kim, Go Eun Yeo, Sung Chan Jeon, Duk Song Cho, You Jin Han. The Influence of Iron Deficiency onHelicobacter pyloriEradication. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2016; 16(2): 82 doi: 10.7704/kjhugr.2016.16.2.82
|
| 24 |
Diogo Branquinho, Nuno Miguel Peres de Almeida, Carlos Gregório, Adriano Casela, Maria Manuel Donato, Luís Tomé. Twelve-day quintuple regime containing four antibiotics as a rescue therapy for Helicobacter pylori eradication in the central region of Portugal. Revista Española de Enfermedades Digestivas 2017; 109 doi: 10.17235/reed.2017.4759/2016
|
| 25 |
Partha Karmakar, Vishwanath Gaitonde. Promising Recent Strategies with Potential Clinical Translational Value to Combat Antibacterial Resistant Surge. Medicines 2019; 6(1): 21 doi: 10.3390/medicines6010021
|
| 26 |
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats. DARU Journal of Pharmaceutical Sciences 2021; 29(1): 13 doi: 10.1007/s40199-020-00377-2
|
| 27 |
Yongfu Shao, Rongdan Lu, Yunben Yang, Qiancheng Xu, Bojun Wang, Guoliang Ye. Antibiotic resistance of Helicobacter pylori to 16 antibiotics in clinical patients. Journal of Clinical Laboratory Analysis 2018; 32(4) doi: 10.1002/jcla.22339
|
| 28 |
Beom Jin Kim, Chang‐Hun Yang, Hyun Joo Song, Seong Woo Jeon, Gwang Ha Kim, Hyun‐Soo Kim, Tae Ho Kim, Ki‐Nam Shim, Il‐Kwun Chung, Moo In Park, Il Ju Choi, Ji Hyun Kim, Byung‐Wook Kim, Gwang Ho Baik, Sok Won Han, Hyang Eun Seo, Woon Tae Jung, Jung Hwan Oh, Sang Gyun Kim, Jun Haeng Lee, Sue K. Park, Byung‐Joo Park, Bo Ram Yang, Joongyub Lee, Jae G. Kim. Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success. Helicobacter 2019; 24(5) doi: 10.1111/hel.12646
|
| 29 |
Jianglong Shi, Liyun Liu, Jian Li, Xiaoju Ma, Hairong Qiu, Tao Shen. Efficacy and safety of Zuojin Pill for chronic gastritis. Medicine 2020; 99(29): e21248 doi: 10.1097/MD.0000000000021248
|
| 30 |
Azucena Arévalo, William Alberto Otero, Alba Alicia Trespalacios. Helicobacter pylori: resistencia múltiple en pacientes de Bogotá, Colombia. Biomédica 2019; 39: 125 doi: 10.7705/biomedica.v39i3.4437
|
| 31 |
Fatemeh Forooghi Nia, Atefe Rahmati, Mona Ariamanesh, Jafar Saeidi, Ahmad Ghasemi, Mahnaz Mohtashami. The Anti-Helicobacter pylori effects of Limosilactobacillus reuteri strain 2892 isolated from Camel milk in C57BL/6 mice. World Journal of Microbiology and Biotechnology 2023; 39(5) doi: 10.1007/s11274-023-03555-x
|
| 32 |
Tadeja Pintar, Niko Kaliterna, Tanja Carli. The need for a patient-tailored Helicobacter pylori eradication protocol prior to bariatric surgery. Journal of International Medical Research 2018; 46(7): 2696 doi: 10.1177/0300060518769543
|
| 33 |
Yan Sun, Jun Zhang. Helicobacter pylori recrudescence and its influencing factors. Journal of Cellular and Molecular Medicine 2019; 23(12): 7919 doi: 10.1111/jcmm.14682
|
| 34 |
Farideh Siavoshi, Parastoo Saniee, Reza Malekzadeh. Effective antimicrobial activity of rifabutin against multidrug‐resistant Helicobacter pylori. Helicobacter 2018; 23(6) doi: 10.1111/hel.12531
|
| 35 |
R. Contreras-Omaña, A.E. Escorcia-Saucedo, J.A. Velarde-Ruiz Velasco. Prevalence and impact of antimicrobial resistance in gastrointestinal infections: A review. Revista de Gastroenterología de México (English Edition) 2021; 86(3): 265 doi: 10.1016/j.rgmxen.2021.06.004
|
| 36 |
Xiwen Geng, Wen Li, Zhenghong Chen, Sizhe Gao, Wei Hong, Xiaoran Ge, Guihua Hou, Zhekai Hu, Yabin Zhou, Beini Zeng, Wenjuan Li, Jihui Jia, Yundong Sun. The Bifunctional Enzyme SpoT Is Involved in the Clarithromycin Tolerance of Helicobacter pylori by Upregulating the Transporters HP0939, HP1017, HP0497, and HP0471. Antimicrobial Agents and Chemotherapy 2017; 61(5) doi: 10.1128/AAC.02011-16
|
| 37 |
Bin Huang, Shengju Yan, Chao Chen, Shandong Ye. Effect of 25-hydroxyvitamin D on Helicobacter pylori eradication in patients with type 2 diabetes. Wiener klinische Wochenschrift 2019; 131(3-4): 75 doi: 10.1007/s00508-018-1416-y
|
| 38 |
Pavimol Angsantikul, Soracha Thamphiwatana, Qiangzhe Zhang, Kevin Spiekermann, Jia Zhuang, Ronnie H. Fang, Weiwei Gao, Marygorret Obonyo, Liangfang Zhang. Coating Nanoparticles with Gastric Epithelial Cell Membrane for Targeted Antibiotic Delivery against Helicobacter pylori Infection. Advanced Therapeutics 2018; 1(2) doi: 10.1002/adtp.201800016
|
| 39 |
Menghua Xiong, Yan Bao, Xin Xu, Hua Wang, Zhiyuan Han, Zhiyu Wang, Yeqing Liu, Songyin Huang, Ziyuan Song, Jinjing Chen, Richard M. Peek, Lichen Yin, Lin-Feng Chen, Jianjun Cheng.
Selective killing of
Helicobacter pylori
with pH-responsive helix–coil conformation transitionable antimicrobial polypeptides
. Proceedings of the National Academy of Sciences 2017; 114(48): 12675 doi: 10.1073/pnas.1710408114
|
| 40 |
Yu Wang, Jiong Tang, Su Zhou, Tian-Tian Liang, Fang-Fang Wang, Hong Ning. Effectiveness and Safety of Rifaximin-Containing Regimens for Helicobacter pylori Eradication: Systematic Review – Are They Potential Eradication Regimens?. Infection and Drug Resistance 2022; : 3733 doi: 10.2147/IDR.S371131
|
| 41 |
Brian White, Maria Winte, Joshua DeSipio, Sangita Phadtare. Clinical Factors Implicated in Antibiotic Resistance in Helicobacter pylori Patients. Microorganisms 2022; 10(2): 322 doi: 10.3390/microorganisms10020322
|
| 42 |
Mohammad Zamani, Vahid Zamani, Mohammad H. Derakhshan, Javad Shokri-Shirvani. The efficacy of first-line regimens for Helicobacter pylori eradication in different continents. Medicine 2018; 97(50): e13682 doi: 10.1097/MD.0000000000013682
|
| 43 |
Ivana Jukic, Jonatan Vukovic, Doris Rusic, Josko Bozic, Josipa Bukic, Dario Leskur, Ana Seselja Perisin, Darko Modun. Adherence to Maastricht V/Florence consensus report for the management ofHelicobacter pyloriinfection among primary care physicians and medical students in Croatia: A cross‐sectional study. Helicobacter 2021; 26(2) doi: 10.1111/hel.12775
|
| 44 |
Yan Zhou, Zishao Zhong, Shengjuan Hu, Jing Wang, Yanhong Deng, Ximei Li, Xianmei Chen, Xue Li, Yuanyuan Tang, Xiaofei Li, Qian Hao, Jun Liu, Tian Sang, Yang Bo, Feihu Bai.
A Survey of
Helicobacter pylori
Antibiotic-Resistant Genotypes and Strain Lineages by Whole-Genome Sequencing in China
. Antimicrobial Agents and Chemotherapy 2022; 66(6) doi: 10.1128/aac.02188-21
|
| 45 |
Razieh Sadat Hosseini, Ghorbanali Rahimian, Mohammad Hadi Shafigh, Majid Validi, Mansoor Khaledi, Abolfazl Gholipour. Correlation between clarithromycin resistance, virulence factors and clinical characteristics of the disease in Helicobacter pylori infected patients in Shahrekord, Southwest Iran. AMB Express 2021; 11(1) doi: 10.1186/s13568-021-01310-9
|
| 46 |
Mika Miura, Masahiko Ohtaka, Mitsuhiko Hanawa, Naoki Shimura, Yoshioki Yoda, Sho Suzuki. Gastric Mucosal Atrophy Might Be Associated with the Efficacy of First-Line Therapy Using Vonoprazan for <i>Helicobacter pylori</i>. Open Journal of Gastroenterology 2017; 7(09): 243 doi: 10.4236/ojgas.2017.79026
|
| 47 |
Seung Joo Kang, Boram Park, Cheol Min Shin. Helicobacter pylori Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and H. pylori Prevalence. Journal of Clinical Medicine 2019; 8(9): 1324 doi: 10.3390/jcm8091324
|